S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism

• Published in: Nitric oxide Vol. 58; pp. 20 - 27
• Main Authors: Liu, Taiming, Schroeder, Hobe J., Zhang, Meijuan, Wilson, Sean M., Terry, Michael H., Longo, Lawrence D., Power, Gordon G., Blood, Arlin B.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 31.08.2016
• Subjects: Animals; Calcium Channel Blockers - pharmacology; Calcium Channels, L-Type - physiology; Cyclic GMP - physiology; Cysteine - analogs & derivatives; Cysteine - pharmacology; Diltiazem - pharmacology; Female; Femoral Artery - drug effects; Femoral Artery - physiology; Fetus; Fetus - blood supply; Indazoles - pharmacology; L-type calcium channel; Male; Mesenteric Arteries - drug effects; Mesenteric Arteries - physiology; Nifedipine - pharmacology; NO/cGMP pathway; Oxadiazoles - pharmacology; Quinoxalines - pharmacology; S-Nitrosoglutathione - pharmacology; S-nitrosothiol; S-Nitrosothiols - pharmacology; Sheep; Soluble Guanylyl Cyclase - metabolism; Vasodilation - drug effects; Vasodilator Agents - pharmacology; YC-1; D-cysNO; GSNO; PKG; sGC; PKI; TEA; NO/cGMP pathway; L-cysNO; K-H solution; L-Ca2+ channel; BKCa; Fetus; Sheep; SNOs; S-nitrosothiol; L-type calcium channel; 5-HT; Cyto-D; EDHF; ODQ; MAP
• ISSN: 1089-8603; 1089-8611
• DOI: 10.1016/j.niox.2016.05.006

S-nitrosothiols (SNOs) are metabolites of NO with potent vasodilatory activity. Our previous studies in sheep indicated that intra-arterially infused SNOs dilate the mesenteric vasculature more than the femoral vasculature. We hypothesized that the mesenteric artery is more responsive to SNO-mediated vasodilation, and investigated various steps along the NO/cGMP pathway to determine the mechanism for this difference. In anesthetized adult sheep, we monitored the conductance of mesenteric and femoral arteries during infusion of S-nitroso-l-cysteine (L-cysNO), and found mesenteric vascular conductance increased (137 ± 3%) significantly more than femoral conductance (26 ± 25%). Similar results were found in wire myography studies of isolated sheep mesenteric and femoral arteries. Vasodilation by SNOs was attenuated in both vessel types by the presence of ODQ (sGC inhibitor), and both YC-1 (sGC agonist) and 8-Br-cGMP (cGMP analog) mediated more potent relaxation in mesenteric arteries than femoral arteries. The vasodilatory difference between mesenteric and femoral arteries was eliminated by antagonists of either protein kinase G or L-type Ca2+ channels. Western immunoblots showed a larger L-type Ca2+/sGC abundance ratio in mesenteric arteries than in femoral arteries. Fetal sheep mesenteric arteries were more responsive to SNOs than adult mesenteric arteries, and had a greater L-Ca2+/sGC ratio (p = 0.047 and r = −0.906 for correlation between Emax and L-Ca2+/sGC). These results suggest that mesenteric arteries, especially those in fetus, are more responsive to SNO-mediated vasodilation than femoral arteries due to a greater role of the L-type calcium channel in the NO/cGMP pathway. •Mesenteric artery is more responsive to SNO-mediated vasodilation than femoral.•The differential responses result from intrinsic difference on L-type Ca2+ channel.•Mesenteric artery has larger L-type Ca2+/sGC abundance ratio than femoral.•Fetal sheep mesenteric artery is also more responsive to SNO than femoral.